Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Jaykaran Charan and Rimple Kaur.
Jaykaran Charan
Connection Strength
1.562
Rimple Kaur
  1. Tocilizumab in COVID-19: a study of adverse drug events reported in the WHO database. Expert Opin Drug Saf. 2021 Sep; 20(9):1125-1136.
    View in: PubMed
    Score: 0.238
  2. Adverse Events Reported From  COVID-19 Vaccine Trials: A Systematic Review. Indian J Clin Biochem. 2021 Oct; 36(4):427-439.
    View in: PubMed
    Score: 0.234
  3. Rapid review of suspected adverse drug events due to remdesivir in the WHO database; findings and implications. Expert Rev Clin Pharmacol. 2021 Jan; 14(1):95-103.
    View in: PubMed
    Score: 0.230
  4. Favipiravir Use in COVID-19: Analysis of Suspected Adverse Drug Events Reported in the WHO Database. Infect Drug Resist. 2020; 13:4427-4438.
    View in: PubMed
    Score: 0.230
  5. Use of Complementary and Alternative Medicine (CAM) and Home Remedies by COVID-19 Patients: A Telephonic Survey. Indian J Clin Biochem. 2020 Oct 31; 1-4.
    View in: PubMed
    Score: 0.228
  6. Snapshot of COVID-19 Related Clinical Trials in India. Indian J Clin Biochem. 2020 Oct; 35(4):418-422.
    View in: PubMed
    Score: 0.224
  7. Cardiovascular Adverse Events Reported from COVID-19 Vaccines: A Study Based on WHO Database. Int J Gen Med. 2021; 14:3909-3927.
    View in: PubMed
    Score: 0.120
  8. Household Transmission of COVID-19: A Cross-Sectional Study. Infect Drug Resist. 2020; 13:4637-4642.
    View in: PubMed
    Score: 0.058
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.